4526 — Riken Vitamin Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeMid CapNeutral

Annual income statement for Riken Vitamin Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	79,231	88,750	91,484	95,582	96,300
Cost of Revenue
Gross Profit	25,565	27,244	29,886	31,270	29,768
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	73,651	81,642	82,618	87,920	89,354
Operating Profit	5,580	7,108	8,866	7,662	6,946
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	20,313	7,857	11,909	12,706	10,244
Provision for Income Taxes
Net Income After Taxes	21,598	6,417	8,760	9,392	7,040
Minority Interest
Net Income Before Extraordinary Items
Net Income	21,582	6,414	8,757	9,389	7,037
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	21,582	6,414	8,755	9,388	7,035
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	663	197	280	329	239
Dividends per Share